PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...
The approval of the Wegovy pill comes months before Novo Nordisk rival Eli Lilly and Company expects FDA approval of its ...
Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1 ...
In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...
Medcare Royal Specialty Hospital in Al Qusais will provide the newly licensed treatment, called Itvisma, to patients with ...
The National on MSN
UAE-approved drug offers hope to older children with spinal muscular atrophy
However, this medicine is suitable only for infants, while Itvisma, now approved by the Emirates Drug Establishment after the thumbs up in November from the US Food and Drug Administration (FDA), can ...
Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided ...
NASA opens the International Space Station for scientists and researchers, inviting them to use the benefits of microgravity ...
The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's cholesterol pill ...
Nine drugmakers are set to unveil deals with the Trump administration to lower the prices of some of their drugs, marking the ...
One round of IVF costs up to $40,000. For millions of Californians, that barrier to parenthood just disappeared thanks to a new mandate.
CareDx, Inc. reports its first net profit in a decade with improved cash flow and margins. Click for this updated look at CDNA stock prospects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback